10058 Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices 

Study. The iron status of all of these 

subjects is well characterized, including 

measurement of plasma ferritin and 

soluble transferrin receptor along with 

hemoglobin/hematocrit. These 

laboratory values allow each subject to 

be defined as (1) iron replete, (2) iron 

deficient without anemia or (3) iron 

deficiency anemia. The responses to 

these questions will be correlated with 

the laboratory test values to determine 

the relationship between blood donation 

and the development of RLS and pica 

and will establish its prevalence in 

these populations. 

Frequency of Response: Twice. 

Affected Public: Individuals. Type of 

Respondents: Adult blood donors. The 

annual reporting burden is a follows: 

Estimated Number of Respondents: 

Baseline visit: 2,340. Follow up Visit: 

1,530; Estimated Number of Responses 

per Respondent: 1. Average Burden of 

Hours per Response: Baseline Visit: 

0.37. Follow up Visit: 0.25; and 

Estimated Total Annual Burden Hours 

Requested: Baseline visit: 866. Follow 

up Visit: 383. The annualized cost to 

respondents is estimated at: Baseline 

Visit: $15,588, Follow up Visit: $6,894 

(based on $18 per hour). There are no 

Capital Costs to report. There are no 

Operating or Maintenance Costs to 

report. 

Type of respondents 

Estimated 

number of 

respondents 

Estimated 

number of responses per 

respondent 

Average 

burden hours 

per response 

Estimated total 

annual burden 

hours 

requested 

Blood donors at Baseline Visit ........................................................................ 2,340 1 0.37 866 

Blood donors at Follow-up Visit ....................................................................... 1,530 1 0.25 383 

Total .......................................................................................................... ........................ ........................ ........................ 1,249 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Dr. George Nemo, 

Project Officer, NHLBI, Two Rockledge 

Center, Suite 10042, 6701 Rockledge 

Drive, Bethesda, MD 20892–7950, or 

call 301–435–0075, or e-mail your 

request to nemog@nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: February 27, 2009. 

George Nemo, 

NHLBI Project Officer, NHLBI, National 

Institutes of Health. 

[FR Doc. E9–4836 Filed 3–6–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel. Minority Biomedical Research Score 

Applications. 

Date: March 25–26, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: John J. Laffan, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18J, Bethesda, 

MD 20892, 301–594–2773, 

laffanjo@mail.nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel. Minority Biomedical Research 

Support Score Applications. 

Date: March 26–27, 2009. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, Room 3AN18, 45 Center 

Drive, Bethesda, MD 20892. (Virtual 

Meeting). 

Contact Person: Rebecca H. Johnson, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18C, Bethesda, 

MD 20892, 301–594–2771, 

johnsonrh@nigms.nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel. Molecular Biology of Hemorrhagic 

Shock. 

Date: March 30, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, Room 3AN18, 45 Center 

Drive, Bethesda, MD 20892. (Telephone 

Conference Call). 

Contact Person: Brian R. Pike, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN18, Bethesda, MD 

20892, 301–594–3907, pikbr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: February 27, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–4845 Filed 3–6–09; 8:45 am] 

BILLING CODE 4140–01–P 


dwashington3 on PROD1PC60 with NOTICES